National Center for Advancing Translational Sciences; Amended Notice of Meeting, 71911 [2024-19740]
Download as PDF
<![CDATA[
Federal Register / Vol. 89, No. 171 / Wednesday, September 4, 2024 / Notices
Place: National Institute on Aging, 5601
Fishers Lane Rockville, MD 20892 (Virtual
Meeting).
Contact Person: Mariel Jais, PharmD,
Scientific Review Officer, National Institute
of Aging, National Institute of Health, 5601
Fishers Lane, Room 2E400, Rockville, MD
20852, (301) 594–2614, mariel.jais@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: August 28, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–19753 Filed 9–3–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Integrative Health; Notice of Closed
Meetings
ddrumheller on DSK120RN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Integrative Health
Special Emphasis Panel; Leveraging Data at
Scale to Understand Natural Product Impacts
on Whole Person Health (R01 Clinical Trial
Not Allowed).
Date: October 24, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Complementary
and Integrative Health, Democracy II, 6707
Democracy Blvd., Bethesda, MD 20892.
Contact Person: Shiyong Huang, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, Division of Extramural Activities,
NCCIH/NIH, 6707 Democracy Boulevard,
Suite 401, Bethesda, MD 20817,
shiyong.huang@nih.gov.
Name of Committee: National Center for
Complementary and Integrative Health
Special Emphasis Panel; Limited
Competition: Research Resource for Natural
Product Nuclear Magnetic Resonance Data
(R24 Clinical Trial Not Allowed).
Date: October 24, 2024.
Time: 10:00 a.m. to 5:00 p.m.
VerDate Sep<11>2014
21:26 Sep 03, 2024
Jkt 262001
71911
Agenda: To review and evaluate grant
applications.
Place: National Center for Complementary
and Integrative Health, Democracy II, 6707
Democracy Blvd., Bethesda, MD 20892.
Contact Person: Shiyong Huang, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, Division of Extramural Activities,
NCCIH/NIH, 6707 Democracy Boulevard,
Suite 401, Bethesda, MD 20817,
shiyong.huang@nih.gov.
Name of Committee: National Center for
Complementary and Integrative Health
Special Emphasis Panel; Botanical Dietary
Supplements Translational Research Teams
(RM1 Clinical Trial Required).
Date: October 24–25, 2024.
Time: 10:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Complementary
and Integrative Health, Democracy II, 6707
Democracy Blvd., Bethesda, MD 20892.
Contact Person: Shiyong Huang, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, Division of Extramural Activities,
NCCIH/NIH, 6707 Democracy Boulevard,
Suite 401, Bethesda, MD 20817,
shiyong.huang@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: August 28, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
Dated: August 28, 2024.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; SEP–11:
NCI Clinical and Translational Cancer
Research.
Date: October 2, 2024.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W608, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Nadeem Khan, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W608, Rockville, Maryland
20850, 240–276–5856, nadeem.khan@
nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Integrating
Biospecimen Science Approaches.
Date: October 2, 2024.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W526, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Viktoriya Sidorenko,
Ph.D., Scientific Review Officer, Program and
Review Extramural Staff Training Office,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W526, Rockville, Maryland
20850, 240–276–5073, viktoriya.sidorenko@
nih.gov.
[FR Doc. 2024–19814 Filed 9–3–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Center for
Advancing Translational Sciences
Special Emphasis Panel, from November
6, 2024, 9:30 a.m. to November 7, 2024,
1:00 p.m., National Institutes of Health,
9609 Medical Center Drive, Rockville,
MD, 20850 which was published in the
Federal Register on August 20, 2024, 89
FR 67456.
The meeting dates and times is being
changed due to the availability of
members with required expertise; start
date & time will change from 11/06/24
9:30 a.m. to 10/29/24 10:00 a.m.; end
date & time will change from 11/07/24
1:00 p.m. to 10/30/24 2:00 p.m. The
meeting is closed to the public.
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
[FR Doc. 2024–19740 Filed 9–3–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
E:\FR\FM\04SEN1.SGM
04SEN1
]]>Agencies
[Federal Register Volume 89, Number 171 (Wednesday, September 4, 2024)]
[Notices]
[Page 71911]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-19740]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Advancing Translational Sciences; Amended
Notice of Meeting
Notice is hereby given of a change in the meeting of the National
Center for Advancing Translational Sciences Special Emphasis Panel,
from November 6, 2024, 9:30 a.m. to November 7, 2024, 1:00 p.m.,
National Institutes of Health, 9609 Medical Center Drive, Rockville,
MD, 20850 which was published in the Federal Register on August 20,
2024, 89 FR 67456.
The meeting dates and times is being changed due to the
availability of members with required expertise; start date & time will
change from 11/06/24 9:30 a.m. to 10/29/24 10:00 a.m.; end date & time
will change from 11/07/24 1:00 p.m. to 10/30/24 2:00 p.m. The meeting
is closed to the public.
Dated: August 28, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2024-19740 Filed 9-3-24; 8:45 am]
BILLING CODE 4140-01-P
